Brief: Control Bionics Says FY Revenue From Ordinary Activities A$4.5 Mln
24/08/2022 13:28
Aug 24 (Reuters) - Control Bionics Ltd CBL.AX :
* FY REVENUE FROM ORDINARY ACTIVITIES UP 13% TO A$4.5
MILLION
* FY LOSS FOR YEAR ATTRIBUTABLE A$6.1 MILLION VERSUS LOSS
A$3.6
MILLION
Source text for Eikon: ID:nASX66xx7K
Further company coverage: CBL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device